BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilcox RA. Cutaneous T-cell lymphoma: 2014 Update on diagnosis, risk-stratification, and management: Cutaneous T-Cell Lymphoma. Am J Hematol 2014;89:837-51. [DOI: 10.1002/ajh.23756] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 2016;91:151-65. [PMID: 26607183 DOI: 10.1002/ajh.24233] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
2 Qiang JK, Marinas JE, Sajic D, Yeung J. Serpiginous mycosis fungoides in a 21-year-old man. JAAD Case Rep 2015;1:82-4. [PMID: 27051691 DOI: 10.1016/j.jdcr.2015.01.009] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 van Raalte DH, Beishuizen C, Stradmeijer MD, Houtenbos I, ten Kate RW. Malignant cutaneous lesions. BMJ Case Rep 2015;2015:bcr2015210169. [PMID: 26272959 DOI: 10.1136/bcr-2015-210169] [Reference Citation Analysis]
4 Devata S, Wilcox RA. Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents. Am J Clin Dermatol 2016;17:225-37. [DOI: 10.1007/s40257-016-0177-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
5 Cabello I, Servitje O, Corbella X, Bardés I, Pintó X. Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma. Clin Exp Dermatol 2017;42:276-81. [DOI: 10.1111/ced.13044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
6 Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood 2015;126:454-62. [PMID: 26065657 DOI: 10.1182/blood-2015-02-585059] [Cited by in Crossref: 112] [Cited by in F6Publishing: 90] [Article Influence: 16.0] [Reference Citation Analysis]
7 Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 2019;94:1027-41. [PMID: 31313347 DOI: 10.1002/ajh.25577] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
8 Meyer N. [What's new in oncodermatology in 2015?]. Ann Dermatol Venereol 2015;142 Suppl 3:S36-48. [PMID: 26792413 DOI: 10.1016/S0151-9638(16)30005-9] [Reference Citation Analysis]
9 Frankel AE, Woo JH, Ahn C, Foss FM, Duvic M, Neville PH, Neville DM. Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma. Haematologica 2015;100:794-800. [PMID: 25795722 DOI: 10.3324/haematol.2015.123711] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
10 Eren R, Nizam N, Doğu MH, Mercan S, Erdemir AV, Suyanı E. Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides. Ann Hematol 2016;95:1853-7. [PMID: 27510180 DOI: 10.1007/s00277-016-2779-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Fatemi Naeini F, Sadeghiyan H, Pourazizi M, Najafian J, Abtahi-Naeini B. Characteristics of Primary Cutaneous T-Cell Lymphoma in Iran: A 10-Year Retrospective Study. Int Sch Res Notices 2014;2014:820921. [PMID: 27437467 DOI: 10.1155/2014/820921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 de Graauw E, Beltraminelli H, Simon HU, Simon D. Eosinophilia in Dermatologic Disorders. Immunol Allergy Clin North Am 2015;35:545-60. [PMID: 26209899 DOI: 10.1016/j.iac.2015.05.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
13 Virmani P, Zain J, Rosen ST, Myskowski PL, Querfeld C. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome. Dermatologic Clinics 2015;33:807-18. [DOI: 10.1016/j.det.2015.05.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
14 Ring H, Hussain A, Jemec G, Gniadecki R, Gjerdrum L, Mogensen M. Imaging of cutaneous T‐cell lymphomas by optical coherence tomography – a case series study. J Eur Acad Dermatol Venereol 2016;30:1228-9. [DOI: 10.1111/jdv.13157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Zhou L, Zheng H, Huang X, Zhu L, Wu S, Zeng C, Yang L, Chen S, Luo G, Du X, Li Y. Different genetic alteration of A20 in a Sézary syndrome case with Vα2-Jα22 T cell clone. Asia-Pac J Clin Oncol 2018;14:e116-23. [DOI: 10.1111/ajco.12672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
16 Wilcox RA. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 2017;92:1085-102. [PMID: 28872191 DOI: 10.1002/ajh.24876] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
17 da Silva Almeida AC, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen CP, Vermeer MH, Rabadan R, Ferrando A, Palomero T. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. Nat Genet 2015;47:1465-70. [PMID: 26551667 DOI: 10.1038/ng.3442] [Cited by in Crossref: 209] [Cited by in F6Publishing: 195] [Article Influence: 29.9] [Reference Citation Analysis]
18 Alberti-violetti S, Talpur R, Schlichte M, Sui D, Duvic M. Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to Treatment. Clinical Lymphoma Myeloma and Leukemia 2015;15:e105-12. [DOI: 10.1016/j.clml.2015.02.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
19 Hristov AC, Tejasvi T, A Wilcox R. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 2021. [PMID: 34297414 DOI: 10.1002/ajh.26299] [Reference Citation Analysis]
20 Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol 2018;71:814-20. [DOI: 10.1136/jclinpath-2018-205004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
21 Amber KT, Bloom R, Nouri K. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016;17:71-77. [PMID: 26386881 DOI: 10.1007/s40257-015-0155-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
22 Torrealba MP, Manfrere KC, Miyashiro DR, Lima JF, de M Oliveira L, Pereira NZ, Cury-Martins J, Pereira J, Duarte AJS, Sato MN, Sanches JA. Chronic activation profile of circulating CD8+ T cells in Sézary syndrome. Oncotarget 2018;9:3497-506. [PMID: 29423061 DOI: 10.18632/oncotarget.23334] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
23 Amorim GM, Niemeyer-Corbellini JP, Quintella DC, Cuzzi T, Ramos-E-Silva M. Clinical and epidemiological profile of patients with early stage mycosis fungoides. An Bras Dermatol 2018;93:546-52. [PMID: 30066762 DOI: 10.1590/abd1806-4841.20187106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Amorim GM, Niemeyer-corbellini JP, Quintella DC, Cuzzi T, Ramos-e-silva M. Hypopigmented mycosis fungoides: a 20-case retrospective series. Int J Dermatol 2018;57:306-12. [DOI: 10.1111/ijd.13855] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
25 Nicolay JP, Müller-Decker K, Schroeder A, Brechmann M, Möbs M, Géraud C, Assaf C, Goerdt S, Krammer PH, Gülow K. Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB. Blood 2016;128:805-15. [PMID: 27268084 DOI: 10.1182/blood-2016-01-694117] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
26 Bauman TM, Wichterman CM, Musiek AC, Nemer KM. Hoarseness as a presentation of mycosis fungoides infiltrating the larynx. BMJ Case Rep 2017;2017:bcr-2017-221531. [PMID: 28993359 DOI: 10.1136/bcr-2017-221531] [Reference Citation Analysis]
27 Tan E, Shao H, Friedman M. Mycosis Fungoides of the Rectum: Case Report and Review of the Literature. J Gastrointest Cancer 2016;47:417-9. [PMID: 26195195 DOI: 10.1007/s12029-015-9751-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Ding H, Peterson KL, Correia C, Koh B, Schneider PA, Nowakowski GS, Kaufmann SH. Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells. Leukemia 2017;31:1593-602. [PMID: 27890930 DOI: 10.1038/leu.2016.357] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
29 Sokołowska-Wojdyło M, Olek-Hrab K, Ruckemann-Dziurdzińska K. Primary cutaneous lymphomas: diagnosis and treatment. Postepy Dermatol Alergol 2015;32:368-83. [PMID: 26759546 DOI: 10.5114/pdia.2015.54749] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
30 Amorim GM, Corbellini JPN, Quintella DC, Cuzzi T, Ramos-E-Silva M. Evaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoides. An Bras Dermatol 2018;93:680-5. [PMID: 30156617 DOI: 10.1590/abd1806-4841.20187134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Pak C, Callander NS, Young EW, Titz B, Kim K, Saha S, Chng K, Asimakopoulos F, Beebe DJ, Miyamoto S. MicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells. Integr Biol (Camb) 2015;7:643-54. [PMID: 25998180 DOI: 10.1039/c5ib00071h] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
32 Kim SR, Lewis JM, Cyrenne BM, Monico PF, Mirza FN, Carlson KR, Foss FM, Girardi M. BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition. Oncotarget 2018;9:29193-207. [PMID: 30018745 DOI: 10.18632/oncotarget.25670] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
33 Kohnken R, Fabbro S, Hastings J, Porcu P, Mishra A. Sézary Syndrome: Clinical and Biological Aspects. Curr Hematol Malig Rep 2016;11:468-79. [DOI: 10.1007/s11899-016-0351-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
34 Cabello I, Alia P, Pintó X, Muniesa C, Fernandez-de-Misa R, Peñate Y, Morillo M, Perez-Farriols A, Estrach T, Izu R, Gallardo F, Román C, Cervigón I, Ortiz-Brugues A, Ortiz-Romero PL, Servitje O. Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene. JAMA Dermatol 2018;154:1424-31. [PMID: 30422238 DOI: 10.1001/jamadermatol.2018.3679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Naeini FF, Abtahi-Naeini B, Pourazizi M, Sadeghiyan H, Najafian J. Primary cutaneous lymphomas: A clinical and histological study of 99 cases in Isfahan, Iran. J Res Med Sci 2015;20:827-31. [PMID: 26759567 DOI: 10.4103/1735-1995.170595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
36 Awasthee N, Rai V, Chava S, Nallasamy P, Kunnumakkara AB, Bishayee A, Chauhan SC, Challagundla KB, Gupta SC. Targeting IκappaB kinases for cancer therapy. Semin Cancer Biol 2019;56:12-24. [PMID: 29486318 DOI: 10.1016/j.semcancer.2018.02.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
37 Fatemi Naeini F, Abtahi-Naeini B, Sadeghiyan H, Nilforoushzadeh MA, Najafian J, Pourazizi M. Mycosis fungoides in Iranian population: an epidemiological and clinicopathological study. J Skin Cancer 2015;2015:306543. [PMID: 25694829 DOI: 10.1155/2015/306543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
38 Yu X, Li H, Zhu M, Hu P, Liu X, Qing Y, Wang X, Wang H, Wang Z, Xu J, Tan R, Guo Q, Hui H. Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition. J Invest Dermatol 2020;140:2009-2022.e4. [PMID: 32119867 DOI: 10.1016/j.jid.2019.12.041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Iluta S, Termure DA, Petrushev B, Fetica B, Badea ME, Moldovan-Lazar M, Lenghel M, Csutak C, Roman A, Pasca S, Zimta AA, Jitaru C, Tomuleasa C, Roman RC. Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COP. Diagnostics (Basel) 2020;10:E629. [PMID: 32847118 DOI: 10.3390/diagnostics10090629] [Reference Citation Analysis]
40 Andrews JM, Schmidt JA, Carson KR, Musiek AC, Mehta-Shah N, Payton JE. Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma. EBioMedicine 2019;46:170-83. [PMID: 31358475 DOI: 10.1016/j.ebiom.2019.07.053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
41 Kohnken R, Kodigepalli KM, Mishra A, Porcu P, Wu L. MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients. Leuk Res 2017;52:58-66. [PMID: 27889686 DOI: 10.1016/j.leukres.2016.11.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]